Farallon Capital Management’s Nuvation Bio NUVB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$124K Hold
29,000
﹤0.01% 159
2025
Q4
$260K Buy
+29,000
New +$180K ﹤0.01% 119
2023
Q2
Sell
-1,465,000
Closed -$2.43M 179
2023
Q1
$2.43M Sell
1,465,000
-652,600
-31% -$1.32M 0.01% 135
2022
Q4
$4.07M Sell
2,117,600
-782,400
-27% -$1.58M 0.03% 156
2022
Q3
$6.5M Hold
2,900,000
0.04% 166
2022
Q2
$9.4M Hold
2,900,000
0.06% 141
2022
Q1
$15.3M Buy
2,900,000
+1,470,000
+103% +$8.26M 0.08% 112
2021
Q4
$12.2M Sell
1,430,000
-780,000
-35% -$7.17M 0.07% 117
2021
Q3
$22M Sell
2,210,000
-288,600
-12% -$2.62M 0.12% 98
2021
Q2
$23.3M Sell
2,498,600
-1,400
-0.1% -$16K 0.11% 95
2021
Q1
$26.1M Hold
2,500,000
0.14% 93
2020
Q4
$29.3M Buy
+2,500,000
New +$26M 0.18% 81

Other funds holding NUVB